Offer - Urjas Oil for just ₹ 1
Diabetrol 3 P is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Diabetrol 3 P safe for pregnant women?
Diabetrol 3 P has little to no side effects in pregnant women.
Is the use of Diabetrol 3 P safe during breastfeeding?
Diabetrol 3 P may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Diabetrol 3 P, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Diabetrol 3 P.
What is the effect of Diabetrol 3 P on the Kidneys?
Diabetrol 3 P does not damage the kidneys.
What is the effect of Diabetrol 3 P on the Liver?
Diabetrol 3 P is not harmful for the liver.
What is the effect of Diabetrol 3 P on the Heart?
Using Diabetrol 3 P does not have any harmful effects on the heart.
Diabetrol 3 P should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Diabetrol 3 P unless your doctor advises you to do so -
Is this Diabetrol 3 P habit forming or addictive?
Diabetrol 3 P is not addictive in nature.
Interaction between Food and Diabetrol 3 P
Due to the absence of research, it is difficult to say how Diabetrol 3 P and food will interact.
Interaction between Alcohol and Diabetrol 3 P
Consumption of alcohol and Diabetrol 3 P together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glynase® PresTab® (micronized glyburide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826